IDEXX LABORATORIES INC (IDXX) Stock Price & Overview

NASDAQ:IDXX • US45168D1046

Current stock price

575.72 USD
+5.51 (+0.97%)
At close:
575.72 USD
0 (0%)
After Hours:

The current stock price of IDXX is 575.72 USD. Today IDXX is up by 0.97%. In the past month the price decreased by -12.42%. In the past year, price increased by 38.44%.

IDXX Key Statistics

52-Week Range356.14 - 769.98
Current IDXX stock price positioned within its 52-week range.
1-Month Range562.35 - 666.14
Current IDXX stock price positioned within its 1-month range.
Market Cap
45.839B
P/E
44.05
Fwd P/E
38.84
EPS (TTM)
13.07
Dividend Yield
N/A

IDXX Stock Performance

Today
+0.97%
1 Week
-0.24%
1 Month
-12.42%
3 Months
-16.38%
Longer-term
6 Months -8.94%
1 Year +38.44%
2 Years +6.63%
3 Years +15.13%
5 Years +17.66%
10 Years +635.09%

IDXX Stock Chart

IDEXX LABORATORIES INC / IDXX Daily stock chart

IDXX Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to IDXX. When comparing the yearly performance of all stocks, IDXX is one of the better performing stocks in the market, outperforming 71.73% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

IDXX Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to IDXX. IDXX gets an excellent profitability rating and is at the same time showing great financial health properties.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IDXX Earnings

On February 2, 2026 IDXX reported an EPS of 3.08 and a revenue of 1.09B. The company beat EPS expectations (3.12% surprise) and missed revenue expectations (-0.31% surprise).

Next Earnings DateApr 29, 2026
Last Earnings DateFeb 2, 2026
PeriodQ4 / 2025
EPS Reported$3.08
Revenue Reported1.091B
EPS Surprise 3.12%
Revenue Surprise -0.31%

IDXX Forecast & Estimates

22 analysts have analysed IDXX and the average price target is 768.59 USD. This implies a price increase of 33.5% is expected in the next year compared to the current price of 575.72.

For the next year, analysts expect an EPS growth of 13.42% and a revenue growth 9.17% for IDXX


Analysts
Analysts80.91
Price Target768.59 (33.5%)
EPS Next Y13.42%
Revenue Next Year9.17%

IDXX Groups

Sector & Classification

IDXX Financial Highlights

Over the last trailing twelve months IDXX reported a non-GAAP Earnings per Share(EPS) of 13.07. The EPS increased by 16.18% compared to the year before.


Income Statements
Revenue(TTM)4.30B
Net Income(TTM)1.06B
Industry RankSector Rank
PM (TTM) 24.62%
ROA 31.62%
ROE 65.99%
Debt/Equity 0.48
Chartmill High Growth Momentum
EPS Q2Q%17.56%
Sales Q2Q%14.28%
EPS 1Y (TTM)16.18%
Revenue 1Y (TTM)10.42%

IDXX Ownership

Ownership
Inst Owners95.39%
Shares79.62M
Float79.04M
Ins Owners0.21%
Short Float %2.22%
Short Ratio3.4

About IDXX

Company Profile

IDXX logo image IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

Company Info

IPO: 1991-06-21

IDEXX LABORATORIES INC

One Idexx Drive

Westbrook MAINE 04092 US

CEO: Jonathan J. Mazelsky

Employees: 11000

IDXX Company Website

IDXX Investor Relations

Phone: 12075560300

IDEXX LABORATORIES INC / IDXX FAQ

What does IDEXX LABORATORIES INC do?

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.


What is the stock price of IDEXX LABORATORIES INC today?

The current stock price of IDXX is 575.72 USD. The price increased by 0.97% in the last trading session.


What is the dividend status of IDEXX LABORATORIES INC?

IDXX does not pay a dividend.


What is the ChartMill technical and fundamental rating of IDXX stock?

IDXX has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 7 out of 10.


What is the analyst forecast for IDXX stock?

22 analysts have analysed IDXX and the average price target is 768.59 USD. This implies a price increase of 33.5% is expected in the next year compared to the current price of 575.72.


How is the valuation of IDEXX LABORATORIES INC (IDXX) based on its PE ratio?

The PE ratio for IDEXX LABORATORIES INC (IDXX) is 44.05. This is based on the reported non-GAAP earnings per share of 13.07 and the current share price of 575.72 USD.